Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...
After a Years-long Spike, Humboldt’s Overdose Deaths Seeing Sharp Drop Following a nationwide trend, overdose deaths appear ...
Getting to the underlying issues driving someone's behavior is not a priority in an emergency setting, which represents a ...
PRF-110 is designed to provide extended, non-opiate, post-surgical pain relief. The Company conducted comprehensive in vitro studies to assess the impact of PRF-110 on both non-absorbable and ...